Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2007

01-02-2007 | Concise Article

Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology

Authors: B. Falkensammer, C. Duftner, R. Seiler, M. Pavlic, G. Walder, D. Wilflingseder, H. Stoiber, P. Klein-Weigel, M. Dierich, G. Fraedrich, R. Würzner, M. Schirmer, on behalf of the Innsbruck Abdominal Aortic Aneurysm Trial-Group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2007

Login to get access

Abstract

In a case-control study that included a total of 98 patients and 83 controls, the possible link between various pathogens and abdominal aortic aneurysms was investigated. For 68 patients with abdominal aortic aneurysm and age-matched controls, no differences were detected in the levels of immunoglobulin (Ig)A and IgG Chlamydiaceae and Chlamydophila pneumoniae antibodies. Patients with IgA titers positive for Chlamydophila pneumoniae showed progressive disease (defined as an annual increase of the aneurysm diameter of ≥0.5 cm) more frequently than patients with negative IgA titers (p = 0.046). Polymerase chain reactions performed to detect DNA for Chlamydophila pneumoniae, Chlamydia trachomatis, Chlamydophila psittaci, human cytomegalovirus, Borrelia burgdorferi and Helicobacter pylori in tissue specimens of 30 patients and 15 controls were negative. In summary, Chlamydophila pneumoniae may contribute to aortic aneurysm disease progression, but DNA of this and other pathogens was not found in patients’ specimens.
Literature
2.
go back to reference Lindholt JS, Shi GP (2006) Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31:453–463PubMedCrossRef Lindholt JS, Shi GP (2006) Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31:453–463PubMedCrossRef
3.
go back to reference Lindholt JS, Fasting H, Henneberg EW, Ostergaard L (1999) A review of Chlamydia pneumoniae and atherosclerosis. Eur J Vasc Endovasc Surg 17:283–289PubMedCrossRef Lindholt JS, Fasting H, Henneberg EW, Ostergaard L (1999) A review of Chlamydia pneumoniae and atherosclerosis. Eur J Vasc Endovasc Surg 17:283–289PubMedCrossRef
4.
go back to reference Ngeh J, Anand V, Gupta S (2002) Chlamydia pneumoniae and atherosclerosis—what we know and what we don’t. Clin Microbiol Infect 8:2–13PubMedCrossRef Ngeh J, Anand V, Gupta S (2002) Chlamydia pneumoniae and atherosclerosis—what we know and what we don’t. Clin Microbiol Infect 8:2–13PubMedCrossRef
5.
go back to reference Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Vojdani A, Rosenberg S, Samra Z (2003) Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis 22:300–302PubMed Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Vojdani A, Rosenberg S, Samra Z (2003) Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis 22:300–302PubMed
6.
go back to reference Daus H, Ozbek C, Saage D, Scheller B, Schieffer H, Pfreundschuh M, Gause A (1998) Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 90:83–88PubMedCrossRef Daus H, Ozbek C, Saage D, Scheller B, Schieffer H, Pfreundschuh M, Gause A (1998) Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 90:83–88PubMedCrossRef
7.
go back to reference Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614–1620PubMed Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614–1620PubMed
8.
go back to reference Kalayoglu MV, Byrne GI (1998) A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 66:5067–5072PubMed Kalayoglu MV, Byrne GI (1998) A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 66:5067–5072PubMed
9.
go back to reference Ullmannova V, Haskovec C (2003) The use of housekeeping genes (HKG) as an internal control for the detection of gene expression by quantitative real-time RT-PCR. Folia Biol (Praha) 49:211–216 Ullmannova V, Haskovec C (2003) The use of housekeeping genes (HKG) as an internal control for the detection of gene expression by quantitative real-time RT-PCR. Folia Biol (Praha) 49:211–216
10.
go back to reference Walder G, Hotzel H, Brezinka C, Gritsch W, Tauber R, Würzner R, Ploner F (2005) An unusual case of sepsis during pregnancy: recognizing infection with Chlamydophila abortus. Obstet Gynecol 106:1215–1217PubMed Walder G, Hotzel H, Brezinka C, Gritsch W, Tauber R, Würzner R, Ploner F (2005) An unusual case of sepsis during pregnancy: recognizing infection with Chlamydophila abortus. Obstet Gynecol 106:1215–1217PubMed
11.
go back to reference Lindholt JS, Juul S, Vammen S, Lind I, Fasting H, Henneberg EW (1999) Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg 86:634–638PubMedCrossRef Lindholt JS, Juul S, Vammen S, Lind I, Fasting H, Henneberg EW (1999) Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg 86:634–638PubMedCrossRef
12.
go back to reference Lindholt JS, Ashton HA, Scott RA (2001) Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg 34:212–215PubMedCrossRef Lindholt JS, Ashton HA, Scott RA (2001) Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg 34:212–215PubMedCrossRef
13.
go back to reference Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM (2005) Toll-like receptors in giant cell arteritis. Clin Immunol 115:38–46PubMedCrossRef Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM (2005) Toll-like receptors in giant cell arteritis. Clin Immunol 115:38–46PubMedCrossRef
14.
go back to reference Lindholt JS, Stovring J, Ostergaard L, Urbonavicius S, Henneberg EW, Honore B, Vorum H (2004) Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation 109:2097–2102PubMedCrossRef Lindholt JS, Stovring J, Ostergaard L, Urbonavicius S, Henneberg EW, Honore B, Vorum H (2004) Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation 109:2097–2102PubMedCrossRef
15.
go back to reference Maraha B, den Heijer M, Kluytmans J, Peeters M (2004) Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases. Clin Diagn Lab Immunol 11:789–791PubMedCrossRef Maraha B, den Heijer M, Kluytmans J, Peeters M (2004) Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases. Clin Diagn Lab Immunol 11:789–791PubMedCrossRef
Metadata
Title
Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology
Authors
B. Falkensammer
C. Duftner
R. Seiler
M. Pavlic
G. Walder
D. Wilflingseder
H. Stoiber
P. Klein-Weigel
M. Dierich
G. Fraedrich
R. Würzner
M. Schirmer
on behalf of the Innsbruck Abdominal Aortic Aneurysm Trial-Group
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0245-5

Other articles of this Issue 2/2007

European Journal of Clinical Microbiology & Infectious Diseases 2/2007 Go to the issue

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine